WHO Regulatory Agency Benchmarking System Set For Early 2019 Launch
Executive Summary
The WHO is planning to introduce a new version of its tool for evaluating the “maturity level” of national drug regulatory agencies across the world as part of a drive to strengthen regulatory systems and make them more effective and transparent. It is also introducing the concept of "WHO-listed authority".
You may also be interested in...
WHO Forges Ahead With New Framework To List Regulatory Authorities
The World Health Organization is to consult on a policy document explaining how it intends to evaluate and list regulatory authorities that meet certain criteria. The new concept of “WHO-listed authority” will replace the current “stringent regulatory authority.”
WHO Consults On New Framework To Evaluate And List Regulatory Authorities
The new framework, when finalized, will replace the widely-recognized concept of "stringent regulatory authorities."
Public/Private Cooperation, Tailored Assistance Deemed Key To Enhancing Quality Of US Drug Imports
Public health experts tell committee that much work lies ahead in strengthening the regulatory systems of low-and middle-income countries, and recommend ways to bolster these systems and improve the quality of imports.